For this reason, we have proposed a novel therapeutic model in which Qa-1-restricted CD8+ Treg cells may be harnessed to target tissue-specific antigens and thereby indirectly suppress pathogenic autoreactive T cells for the treatment of autoimmune diseases. Here, CD8A is linked to autoimmune disease.